Head-to-head
LillyDirect (Zepbound) vs bmiMD
Compared on tirzepatide across the eight dimensions this database records. They differ on 6 of those eight. bmiMD is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
LillyDirect (Zepbound) is $449 a month all-in for tirzepatide; bmiMD is $179. Over twelve months that is $5,388 against $1,668. Value Scores are 46.3 and 91.6 out of 100.
Tirzepatide
Plan pages: LillyDirect (Zepbound) plans · bmiMD plans
At 10 mg/week, LillyDirect (Zepbound) is $449 a month all-in and bmiMD is $179 — $270 apart, or $3,240 across a year. Over twelve months the totals are $5,388 (billed monthly) and $1,668 (prepaid term).
LillyDirect (Zepbound) prices tirzepatide by dose: $299 per month at 2.5 mg rising to $449 at 7.5 mg, a difference of $150 a month between the bottom and top of the ladder.
bmiMD charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | LillyDirect (Zepbound) | Rank | bmiMD | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $299 | 18/31 | $179 | 5/31 | bmiMD by $120 |
| 5 mg | $399 | 14/17 | $179 | 3/17 | bmiMD by $220 |
| 7.5 mg | $449 | 16/17 | $179 | 3/17 | bmiMD by $270 |
| 10 mg | $449 | 24/27 | $179 | 3/27 | bmiMD by $270 |
| 12.5 mg | $449 | 16/17 | $179 | 3/17 | bmiMD by $270 |
| 15 mg | $449 | 16/17 | $179 | 3/17 | bmiMD by $270 |
bmiMD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, LillyDirect (Zepbound) sits 23 of 27 on all-in monthly cost and bmiMD sits 2. There are 20 other programs priced between them. The field median is $339 and the floor is $169, so bmiMD is below the median and the other is above it. LillyDirect (Zepbound) is $280 above the cheapest tirzepatide program on record. bmiMD is $10 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — LillyDirect (Zepbound) undercuts it by $0, bmiMD by $270. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | LillyDirect (Zepbound) | bmiMD | Cheaper |
|---|---|---|---|
| Month to month | $449 | $179 | bmiMD by $270 |
| 3-month term | — | $159 | only bmiMD publishes this term |
| 6-month term | — | $149 | only bmiMD publishes this term |
| 12-month term | — | $139 | only bmiMD publishes this term |
| Settled dose | LillyDirect (Zepbound) | bmiMD | Difference |
|---|---|---|---|
| 2.5 mg | $3,588 | $2,148 | $1,440 apart |
| 5 mg | $4,788 | $2,148 | $2,640 apart |
| 7.5 mg | $5,388 | $2,148 | $3,240 apart |
| 10 mg | $5,388 | $2,148 | $3,240 apart |
| 12.5 mg | $5,388 | $2,148 | $3,240 apart |
| 15 mg | $5,388 | $2,148 | $3,240 apart |
LillyDirect (Zepbound) publishes no rate for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $5,188 on LillyDirect (Zepbound) and $2,148 on bmiMD — $3,040 apart, and a different gap from the $3,240 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 46.3 for LillyDirect (Zepbound) and 91.6 for bmiMD, against a tirzepatide category floor of $169. bmiMD leads by 45.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| LillyDirect (Zepbound) | 26.4 | 15.0 | 0 | 5 | 46.3 |
| bmiMD | 66.1 | 10.5 | 10 | 5 | 91.6 |
Where the two programs differ
All-in monthly
bmiMD is cheaper month to month — $179 against $449, a gap of $270 every month, or $3,240 across a year if both rates hold.
Cancellation terms
Cancellation differs: LillyDirect (Zepbound) states No subscription lock, while bmiMD states Per provider terms; confirm cancellation policy at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
LillyDirect (Zepbound) asks for None; Journey Program pricing requires refill within 45 days on 7.5 mg+; bmiMD asks for Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
bmiMD charges one price at every dose; LillyDirect (Zepbound) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. LillyDirect (Zepbound)'s figure is verified and bmiMD's is reported. LillyDirect (Zepbound) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $5,388 for LillyDirect (Zepbound) and $1,668 for bmiMD. bmiMD is lower by $3,720 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
LillyDirect (Zepbound) Official site
The manufacturer's own cash channel for FDA-approved Zepbound single-dose vials: $299/month at 2.5 mg, $399 at 5 mg, and $449 for every dose from 7.5 to 15 mg through the Self Pay Journey Program — provided each refill lands within 45 days of the last, otherwise that refill reverts to $599–$1,049 by dose. This is the cheapest FDA-approved tirzepatide in the country and the benchmark every compounded price should be judged against.
It names its compounding pharmacy — Eli Lilly self-pay pharmacy (GiftHealth), recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; Journey Program pricing requires refill within 45 days on 7.5 mg+; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — Lilly investor announcement Dec 1, 2025 + LillyDirect program pages; corroborated by drugs.com pricing review updated Jun 12, 2026
Watch: The 45-day refill window is the whole game: one late refill at 10 mg costs $699 instead of $449.
bmiMD Official site
bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules.
It does not publicly name its compounding pharmacy; the record shows Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose; cancellation is Per provider terms; confirm cancellation policy at enrollment; availability is stated as Availability at enrollment; confirm your state at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com cheapest-compounded-tirzepatide-online, capture verified 2026-07-14
Watch: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Which molecules each one carries
LillyDirect (Zepbound) carries tirzepatide at $449 a month; does not offer semaglutide.
bmiMD carries tirzepatide at $179 a month and semaglutide at $129 a month.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
LillyDirect (Zepbound) does not publish
- no published twelve-month tirzepatide rate
bmiMD does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Availability at enrollment; confirm your state at intake
- no specific cancellation or refund terms
Ask LillyDirect (Zepbound) and bmiMD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. bmiMD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. bmiMD publishes a twelve-month rate of $139 a month against $179 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, bmiMD Official site wins this matchup. If you expect to titrate to the top of the ladder, bmimd's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, lillydirect (zepbound)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. LillyDirect (Zepbound)'s tirzepatide price is verified as of 2026-08-11; bmiMD's is reported as of 2026-07-14.
Questions
Is LillyDirect (Zepbound) or bmiMD cheaper for tirzepatide?
bmiMD is cheaper on all-in monthly cost at 10 mg/week: $179 against $449, a difference of $270 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of LillyDirect (Zepbound) versus bmiMD?
LillyDirect (Zepbound) works out to $5,388 across twelve months and bmiMD to $1,668, on the plan terms each publishes.
Does LillyDirect (Zepbound) or bmiMD raise the price as the dose goes up?
LillyDirect (Zepbound): yes, it prices by dose. bmiMD: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do LillyDirect (Zepbound) and bmiMD differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of LillyDirect (Zepbound) and bmiMD names its pharmacy?
LillyDirect (Zepbound) does — Eli Lilly self-pay pharmacy (GiftHealth). bmiMD does not, recording only Named 503A pharmacy partner (specific pharmacy not publicly identified on pricing page), so who makes its medication cannot be independently verified.
How well evidenced are the LillyDirect (Zepbound) and bmiMD prices?
LillyDirect (Zepbound)'s tirzepatide figure is verified — captured at checkout by our desk on the stated date — captured 2026-08-11. bmiMD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: LillyDirect (Zepbound) official site · bmiMD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.